Advanced lung cancer, which has spread (metastasized) from the primary tumor to distant organs, is associated with lower survival rates. That's because lung cancer becomes more difficult to treat as ...

I have a 54-year-old male patient with stage IIIB non-small-cell lung cancer (NSCLC) of the right lower lobe. He had 1 episode of hemorrhagic pleural effusion that did not recur after drainage. The ...

Historically, non-small cell lung cancer (NSCLC) treatment involved three modalities: surgery, radiation therapy and chemotherapy. In the last two decades, the treatment landscape of NSCLC has greatly ...

In this study, researchers evaluated patients who had incomplete cCRT or experienced progression during or within 42 days of receiving cCRT, with an aim of identifying risk factors for these outcomes.

"There’s a large amount of imaging conducted nowadays for many different clinical reasons. A careful reading finding lung nodules in these images could save lives by detecting lung cancer early." — ...

Sugemalimab application seeks approval for unresectable stage 3 NSCLC post-chemoradiotherapy, supported by phase 3 GEMSTONE-301 study data. The study showed a 36% reduction in disease progression risk ...